Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Return on Assets (2016 - 2025)

Ani Pharmaceuticals' Return on Assets history spans 15 years, with the latest figure at 0.06% for Q4 2025.

  • For Q4 2025, Return on Assets rose 7.0% year-over-year to 0.06%; the TTM value through Dec 2025 reached 0.06%, up 7.0%, while the annual FY2025 figure was 0.06%, 7.0% up from the prior year.
  • Return on Assets for Q4 2025 was 0.06% at Ani Pharmaceuticals, up from 0.03% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.06% in Q4 2025 and bottomed at 0.09% in Q3 2022.
  • The 5-year median for Return on Assets is 0.02% (2024), against an average of 0.02%.
  • The largest annual shift saw Return on Assets fell -6bps in 2021 before it grew 11bps in 2023.
  • A 5-year view of Return on Assets shows it stood at 0.07% in 2021, then increased by 7bps to 0.06% in 2022, then surged by 133bps to 0.02% in 2023, then crashed by -169bps to 0.01% in 2024, then soared by 482bps to 0.06% in 2025.
  • Per Business Quant, the three most recent readings for ANIP's Return on Assets are 0.06% (Q4 2025), 0.03% (Q3 2025), and 0.01% (Q2 2025).